What are examples of osmotic laxatives?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Osmotic Laxatives: Examples and Clinical Applications

The primary osmotic laxatives used in clinical practice are polyethylene glycol (PEG), lactulose, magnesium oxide, and magnesium salts 1.

Specific Osmotic Laxative Agents

First-Line Agents

  • Polyethylene glycol (PEG) 3350: The most commonly recommended osmotic laxative, available over-the-counter at a starting dose of 17 g daily mixed in 8 ounces of liquid 1. PEG is a long-chain polymer of ethylene oxide that works by trapping water in the intestinal lumen.

  • Lactulose: A synthetic disaccharide osmotic laxative, typically initiated at 15 g daily 1. It is the only osmotic agent that has been studied in pregnancy, making it a preferred option for pregnant patients 1.

  • Magnesium oxide (MgO): Started at 400-500 mg daily, though prior studies have used 1,000-1,500 mg daily 1. Use with extreme caution in patients with renal insufficiency and pregnancy due to risk of magnesium accumulation.

Additional Osmotic Agents

  • Macrogol (PEG 4000): A high-molecular-weight polyethylene glycol formulation, sometimes combined with electrolytes 2, 3. Macrogol 4000 is particularly well-tolerated with a preferred taste profile compared to PEG 3350 with electrolytes.

  • Mannitol: An osmotic laxative occasionally used in specific clinical contexts 4.

  • Magnesium salts: Including magnesium hydroxide and other magnesium-based preparations 3.

  • Sorbitol: A sugar alcohol with osmotic properties, sometimes used in combination enema preparations 5.

Key Clinical Distinctions

PEG is generally preferred over lactulose because it causes less bloating, flatulence, and abdominal cramping 1, 3, 6. The 2023 AGA-ACG guidelines specifically note that PEG demonstrates durable response over 6 months and has no clear maximum dose, allowing for flexible titration based on symptom response 1.

Lactulose's main advantage is its safety profile in pregnancy 1, but its side effects (flatulence, bloating, abdominal cramping) can be limiting, particularly at higher doses or in patients with preexisting symptoms 1.

Magnesium-based laxatives require careful patient selection, as they are contraindicated in renal insufficiency where magnesium accumulation can occur 1.

Cost Considerations

All osmotic laxatives are relatively inexpensive, with monthly costs under $50 for PEG, magnesium oxide, and lactulose 1, making them accessible first-line options before considering more expensive prescription secretagogues or prokinetic agents.

References

Research

Constipation--modern laxative therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003

Research

Pharmacological treatment for antipsychotic-related constipation.

The Cochrane database of systematic reviews, 2017

Research

Treatments for intractable constipation in childhood.

The Cochrane database of systematic reviews, 2024

Research

A literature review of two laxatives: lactulose and polyethylene glycol.

British journal of community nursing, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.